Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Skin Care Sales Up 17% In Q1 Fueled By Neutrogena, Aveeno

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson skin care sales increased 17% in the first quarter, fueled by the continued strength of Neutrogena and Aveeno, VP-Investor Relations Helen Short reported in an April 15 sales and earnings presentation. Sales increased 11% operationally and benefited 6% from positive currency effect, she said

You may also be interested in...



Neutrogena Introduces Helioplex Sun Care, Cleansing Pads

Neutrogena Helioplex sun care, formulated with stabilized avobenzone, "blocks more UVA rays than the leading sunscreens available in the U.S.," Johnson & Johnson claims

Neutrogena Introduces Helioplex Sun Care, Cleansing Pads

Neutrogena Helioplex sun care, formulated with stabilized avobenzone, "blocks more UVA rays than the leading sunscreens available in the U.S.," Johnson & Johnson claims

Aveeno Hair Minimizing Entry Makes Positively Smooth Debut In March

Johnson & Johnson is introducing Aveeno Positively Smooth hair minimizing skin care products in March based on the brand's signature soy technology, the company said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel